BioZorb LP Marker F0231Recalls & reported problems
Focal Therapeutics, Inc. · The Marker is a radiographic implantable marker used to mark soft tissue. It is comprised of a bioabsorbable spacer that holds radiopaque marker clips. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00851766006078), received between Sep 5, 2023 and Sep 6, 2023 — classified as 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- Breast Discomfort/Pain2
- Anxiety1
- Itching Sensation1
- Scar Tissue1
- Seroma1
- Sleep Dysfunction1
- Swelling/ Edema1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjurySep 6, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT UNDERWENT A RIGHT PARTIAL MASTECTOMY ON (B)(6) 2020 DURING WHICH A BIOZORB WAS IMPLANTED. PATIENT HAD A PRIOR DIAGNOSIS OF RIGHT BREAST INVASIVE LOBULAR CARCINOMA. PATIENT REPORTED SUFFERED FROM PAIN, A HARD LUMP, DEFORMITY, SCARRING , SENSITIVITY, ITCHING, SWELLING AND REDDENING OF HER SKIN, FIBROSIS, LYMPHEDEMA, SEROMA, AND EDEMA. PATIENT REPORTED IS HAVING ISSUES SLEEPING AND CAUSING DISCOMFORT. NO OTHER INFORMATION IS AVAILABLE.
Patient problems: Anxiety; Breast Discomfort/Pain; Itching Sensation; Scar Tissue; Seroma; Sleep Dysfunction; Swelling/ Edema
MAUDE report 17695483 ↗InjurySep 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT RECEIVED A BIOZORB IN (B)(6) 2022. THE PATIENT COMPLAINTS THAT SHE SUFFERS FROM A HARD PAINFUL LUMP, SENSITIVITY AND CONSTANT SWELLING OF HER BREAST. PATIENT HAS HAD TO RECEIVE PHYSICAL THERAPY DUE TO THE PAIN AND REPORTS A DEFORMITY IN HER BREAST. NO OTHER INFORMATION IS AVAILABLE.
Patient problems: Breast Discomfort/Pain
MAUDE report 17684514 ↗
Other Marker, Radiographic, Implantable devices
- BioZorb F0202Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls192 reports
- BioZorb F0221Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE3 recalls15 reports
- BioZorb F0203Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls51 reports
- BioZorb F0231Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0303Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0304Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0404Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls6 reports
- BioZorb F0331Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page